KASHIWAGI SHINITIROU 柏木伸一郎

… Alternative Names

Kashiwagi Shinichiro 柏木伸一郎

Less

Researcher Number	80637017
Other IDs	https://orcid.org/0000-0002-0460-9599
Affiliation (Current)	2024: 大阪公立大学, 大学院医学研究科, 教授
Affiliation (based on the past Project Information) *help	2022 – 2023: 大阪公立大学, 大学院医学研究科, 准教授 2015 – 2021: 大阪市立大学, 大学院医学研究科, 講師 2013 – 2014: 大阪市立大学, 医学(系)研究科(研究院), 講師
Review Section/Research Field	Principal Investigator Basic Section 55010:General surgery and pediatric surgery-related / General surgery Except Principal Investigator Basic Section 55010:General surgery and pediatric surgery-related / General surgery
Keywords	Principal Investigator トリプルネガティブ乳癌 / 腫瘍免疫 / 腫瘍微小環境 / 乳癌 / 抗体薬物複合体 / 腫瘍免疫応答 / 免疫療法 / 外科 / 病理学 / 免疫学 … More / トランスレーショナルリサーチ / 癌 / Precision medicine / E-cadherin / 上皮間葉転換 / 個別化治療 … More Except Principal Investigator トランスジェニック・マウス / VE-Cadherin / 血管新生阻害 / がん微小環境 / VE-cadherin promoter / 腫瘍血管内皮細胞 / E-cadherin / nestin / 甲状腺未分化癌 / 上皮間葉転換 / 培養細胞株 / 未分化癌 / 甲状腺癌 Less

Development of Breast Cancer Treatment Strategies Based on Dynamic Changes in Tumor Microenvironment Induced by Drug ModificationPrincipal Investigator
- Principal Investigator
  
  柏木伸一郎
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Osaka Metropolitan University
Verification of systemic response and tumor microenvironment change in triple-negative breast cancer based on immune responsePrincipal Investigator
- Principal Investigator
  
  柏木伸一郎
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Osaka Metropolitan University
  Osaka City University
The establishment of an innovative method for isolation of tumor endothelial cells (TECs) supporting the growth of tumor and the application to cancer therapy
- Principal Investigator
  
  藤田寿一
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Osaka City University
Clinical validation of microenvironmental control related to malignant trait acquisition of triple negative breast cancerPrincipal Investigator
- Principal Investigator
  
  Kashiwagi Shinichiro
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Osaka City University
Clinical significance and molecular mechanism elucidation of E-cadherin expression in triple-negative breast cancerPrincipal Investigator
- Principal Investigator
  
  Kashiwagi Shinichiro
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Osaka City University
Involvement of EMT in anaplastic thyroid carcinoma
- Principal Investigator
  
  Onoda Naoyoshi
- Project Period (FY)
  2013 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Osaka City University

All 2023 2022 2020 2019 2018 2017 2016 2015 2014 2013 Other

All Journal Article Presentation

[Journal Article] Clinical verification on the relationship between serum lipid metabolism and the immune activity in breast cancer patients treated with neoadjuvant chemotherapy.2023
- Author(s)
  Goto W, Kashiwagi S, Takada K, Asano Y, Ogisawa K, Morisaki T, Shibutani M, Tanaka H, Maeda K.
- Journal Title
  
  European Journal of Medical Research
  
  Volume: 28 Issue: 1 Pages: 2-2
- DOI
  10.1186/s40001-022-00964-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18046, KAKENHI-PROJECT-19K18067, KAKENHI-PROJECT-22K16468
[Journal Article] Factor analysis of intraoperative bleeding loss and its impact on prognosis in breast cancer.2023
- Author(s)
  Takada K, Kashiwagi S, Iimori N, Kouhashi R, Yabumoto A, Goto W, Asano Y, Tauchi Y, Ogisawa K, Morisaki T, Shibutani M, Tanaka H, Maeda K.
- Journal Title
  
  Anticancer Research
  
  Volume: 43 Issue: 1 Pages: 191-200
- DOI
  10.21873/anticanres.16149
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18067
[Journal Article] Clinical verification of the predictors for febrile neutropenia in breast cancer patients treated with neoadjuvant chemotherapy.2023
- Author(s)
  Goto W, Kashiwagi S, Matsuoka K, Iimori N, Kouhashi R, Yabumoto A, Takada K, Asano Y, Tauchi Y, Ogisawa K, Morisaki T, Shibutani M, Tanaka H, Maeda K.
- Journal Title
  
  Anticancer Research
  
  Volume: 43 Issue: 1 Pages: 247-251
- DOI
  10.21873/anticanres.16156
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18046, KAKENHI-PROJECT-22K16468
[Journal Article] Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer.2023
- Author(s)
  Takada K, Kashiwagi S, Iimori N, Yabumoto A, Goto W, Asano Y, Tauchi Y, Morisaki T, Ogisawa K, Shibutani M, Tanaka H, Maeda K.
- Journal Title
  
  BMC Cancer
  
  Volume: 23 Issue: 1 Pages: 224-224
- DOI
  10.1186/s12885-023-10631-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18067
[Journal Article] Eribulin treatment promotes re-expression of estrogen receptor in endocrine therapy-resistant hormone receptor-positive breast cancer cells.2023
- Author(s)
  Goto W, Kashiwagi S, Iimori N, Kouhashi R, Yabumoto A, Takada K, Asano Y, Tauchi Y, Ogisawa K, Morisaki T, Shibutani M, Tanaka H, Maeda K.
- Journal Title
  
  Anticancer Research
  
  Volume: 43 Issue: 2 Pages: 603-611
- DOI
  10.21873/anticanres.16196
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18046, KAKENHI-PROJECT-19K18067, KAKENHI-PROJECT-22K16468
[Journal Article] Outcome prediction after neoadjuvant chemotherapy (NAC) for breast cancer, using tumor-infiltrating lymphocytes within fibrotic foci of tumor stroma (FF-TILs).2022
- Author(s)
  Kashiwagi S, Asano Y, Takada K, Goto W, Morisaki T, Shibutani M, Tanaka H, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 42 Issue: 3 Pages: 1421-1431
- DOI
  10.21873/anticanres.15612
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18046
[Journal Article] Clinical significance of expression of immunoadjuvant molecules (LAG-3, TIM-3, OX-40) in neoadjuvant chemotherapy for breast cancer.2022
- Author(s)
  Asano Y, Kashiwagi S* Takada K, Ishihara S, Goto W, Morisaki T, Shibutani M, Tanaka H, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 42 Issue: 1 Pages: 125-136
- DOI
  10.21873/anticanres.15466
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038
[Journal Article] Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment2020
- Author(s)
  Goto Wataru、Kashiwagi Shinichiro、Asano Yuka、Takada Koji、Morisaki Tamami、Takahashi Katsuyuki、Fujita Hisakazu、Shibutani Masatsune、Amano Ryosuke、Takashima Tsutomu、Tomita Shuhei、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  BMC Cancer
  
  Volume: 20 Issue: 1 Pages: 1215-1215
- DOI
  10.1186/s12885-020-07673-9
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07943, KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18046
[Journal Article] Predicting therapeutic efficacy of endocrine therapy for stage IV breast cancer by tumor infiltrating lymphocytes2020
- Author(s)
  Asano Yuka、Kashiwagi Shinichiro、Goto Wataru、Takada Koji、Takahashi Katsuyuki、Shibutani Masatsune、Amano Ryosuke、Takashima Tsutomu、Tomita Shuhei、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  Molecular and Clinical Oncology
  
  Volume: 13 Issue: 2 Pages: 195-202
- DOI
  10.3892/mco.2020.2063
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07943, KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18046
[Journal Article] The effects of eribulin on breast cancer microenvironment identified using eribulin-resistant breast cancer cell lines.2020
- Author(s)
  Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Fujita H, Takashima T, Shibutani M, Amano R, Tomita S, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 39 Issue: 8 Pages: 4031-4041
- DOI
  10.21873/anticanres.13559
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18046, KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-19K09054
[Journal Article] Validation of systemic and local tumour immune response to eribulin chemotherapy to treat breast cancer.2020
- Author(s)
  Kashiwagi S, Asano Y, Goto W, Takada K, Morisaki T, Kouhashi R, Yabumoto A, Tanaka S, Takashima T, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 40 Issue: 6 Pages: 3345-3354
- DOI
  10.21873/anticanres.14317
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18046
[Journal Article] Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ2020
- Author(s)
  Takada Koji、Kashiwagi Shinichiro、Asano Yuka、Goto Wataru、Morisaki Tamami、Takahashi Katsuyuki、Fujita Hisakazu、Takashima Tsutomu、Tomita Shuhei、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  BMC Cancer
  
  Volume: 20 Issue: 1 Pages: 513-513
- DOI
  10.1186/s12885-020-07001-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07943, KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18067
[Journal Article] Prediction of sentinel lymph node metastasis using the platelet-to-lymphocyte ratio in T1 breast cancer.2020
- Author(s)
  Takada K, Kashiwagi S, Asano Y, Goto W, Kouhashi R, Yabumoto A, Morisaki T, Shibutani M, Takashima T, Fujita H, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 40 Issue: 4 Pages: 2343-2349
- DOI
  10.21873/anticanres.14202
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K18067, KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17K13225
[Journal Article] Prediction of lymph node metastasis by tumor-infiltrating lymphocytes (TILs) in T1 breast cancer.2020
- Author(s)
  Takada K, Kashiwagi S, Asano Y, Goto W, Kouhashi R, Yabumoto A, Morisaki T, Shibutani M, Takashima T, Fujita H, Hirakawa K, Ohira M.
- Journal Title
  
  BMC Cancer
  
  Volume: 20 Issue: 1 Pages: 598-598
- DOI
  10.1186/s12885-020-07101-y
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08938, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18046, KAKENHI-PROJECT-19K18067
[Journal Article] The effect of smoking on biological change of recurrent breast cancer.2020
- Author(s)
  Takada K, Kashiwagi S, Asano Y, Goto W, Kouhashi R, Yabumoto A, Morisaki T, Fujita H, Shibutani M, Takashima T, Hirakawa K, Ohira M.
- Journal Title
  
  Journal of Translational Medicine
  
  Volume: 18 Issue: 1 Pages: 153-153
- DOI
  10.1186/s12967-020-02307-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18067, KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17K13225, KAKENHI-PROJECT-20K08938
[Journal Article] Prognostic value of quality of life scores in breast cancer patients undergoing preoperative chemotherapy.2019
- Author(s)
  Takada K, Kashiwagi S, Fukui Y, Goto W, Asano Y, Morisaki M, Takashima T, Hirakawa K, Ohira M.
- Journal Title
  
  BJS Open
  
  Volume: 3 Issue: 1 Pages: 38-47
- DOI
  10.1002/bjs5.50108
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-19K18067
[Journal Article] Impact of the occurrence of new lesions on the survival of patients who undergo chemotherapy for metastatic colorectal cancer.2019
- Author(s)
  Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Kashiwagi S, Hirakawa K, Ohira M.
- Journal Title
  
  Molecular and Clinical Oncology
  
  Volume: 10 Pages: 285-292
- DOI
  10.3892/mco.2018.1778
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K10559
[Journal Article] Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer.2019
- Author(s)
  Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.
- Journal Title
  
  BMC Cancer
  
  Volume: 19 Issue: 1 Pages: 615-615
- DOI
  10.1186/s12885-019-5828-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K18067, KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-19K09054
[Journal Article] Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer2019
- Author(s)
  Takada Koji、Kashiwagi Shinichiro、Asano Yuka、Goto Wataru、Takahashi Katsuyuki、Fujita Hisakazu、Takashima Tsutomu、Tomita Shuhei、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  Journal of Translational Medicine
  
  Volume: 17 Issue: 1 Pages: 13-13
- DOI
  10.1186/s12967-019-1773-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17H07023, KAKENHI-PROJECT-19K18038, KAKENHI-PROJECT-19K18067
[Journal Article] Clinical outcomes of recombinant human-soluble thrombomodulin treatment for disseminated intravascular coagulation in solid Tumors.2019
- Author(s)
  Kashiwagi S, Asano Y, Takahashi K, Shibutani M, Amano R, Tomita S, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer research
  
  Volume: 39 Issue: 5 Pages: 2259-2264
- DOI
  10.21873/anticanres.13342
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17K08602
[Journal Article] Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer2018
- Author(s)
  Takada Koji、Kashiwagi Shinichiro、Goto Wataru、Asano Yuka、Takahashi Katsuyuki、Takashima Tsutomu、Tomita Shuhei、Ohsawa Masahiko、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  Journal of Translational Medicine
  
  Volume: 16 Issue: 1 Pages: 86-86
- DOI
  10.1186/s12967-018-1460-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559
[Journal Article] Analysis of HER family (HER1-4) expression as a biomarker in combination therapy with pertuzumab, trastuzumab and docetaxel for advanced HER2-positive breast cancer.2018
- Author(s)
  Takada K, Kashiwagi S*, Goto W, Asano Y, Morisaki T, Fujita H, Takashima T, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 38 Issue: 4 Pages: 2285-2294
- DOI
  10.21873/anticanres.12473
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10559
[Journal Article] Mesenchymal?epithelial Transition and Tumor Vascular Remodeling in Eribulin Chemotherapy for Breast Cancer2018
- Author(s)
  Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Hatano T, Tanaka S, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 38 Issue: 1 Pages: 401-410
- DOI
  10.21873/anticanres.12236
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559
[Journal Article] Eribulin promotes antitumor immune responses in patients with locally advanced or metastatic breast cancer.2018
- Author(s)
  Goto W, Kashiwagi S*, Asano Y, Takada K, Morisaki T, Fujita H, Takashima T, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 38 Issue: 5 Pages: 2929-2938
- DOI
  10.21873/anticanres.12541
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10559
[Journal Article] Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer2018
- Author(s)
  Takada Koji、Kashiwagi Shinichiro、Goto Wataru、Asano Yuka、Takahashi Katsuyuki、Fujita Hisakazu、Takashima Tsutomu、Tomita Shuhei、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  Journal of Translational Medicine
  
  Volume: 16 Issue: 1 Pages: 318-318
- DOI
  10.1186/s12967-018-1692-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559
[Journal Article] Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment2018
- Author(s)
  Kashiwagi S, Tsujio G, Asano Y, Goto W, Takada K, Takahashi K, Morisaki T, Fujita H, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  Journal of translational Medicine
  
  Volume: 16 Issue: 1 Pages: 54-54
- DOI
  10.1186/s12967-018-1443-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17H07023, KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K13225
[Journal Article] Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer2018
- Author(s)
  Goto Wataru、Kashiwagi Shinichiro、Asano Yuka、Takada Koji、Takahashi Katsuyuki、Hatano Takaharu、Takashima Tsutomu、Tomita Shuhei、Motomura Hisashi、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  BMC Cancer
  
  Volume: 18 Issue: 1 Pages: 1137-1137
- DOI
  10.1186/s12885-018-5051-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559
[Journal Article] Prediction of the treatment response to pre-operative chemotherapy in breast cancer by the checkpoint protein expression2018
- Author(s)
  Asano Y, Kashiwagi S, Goto W, Takada K, Takahashi K, Morisaki T, Fujita H, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  Journal of translational Medicine
  
  Volume: 16 Issue: 1 Pages: 87-87
- DOI
  10.1186/s12967-018-1458-y
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17K13225, KAKENHI-PROJECT-17H07023, KAKENHI-PROJECT-17K08602
[Journal Article] Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment2018
- Author(s)
  Takada Koji、Kashiwagi Shinichiro、Goto Wataru、Asano Yuka、Takahashi Katsuyuki、Hatano Takaharu、Takashima Tsutomu、Tomita Shuhei、Motomura Hisashi、Ohsawa Masahiko、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  British Journal of Cancer
  
  Volume: 119 Issue: 5 Pages: 572-579
- DOI
  10.1038/s41416-018-0197-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17H07023
[Journal Article] Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer2018
- Author(s)
  Takada Koji、Kashiwagi Shinichiro、Goto Wataru、Asano Yuka、Takahashi Katsuyuki、Morisaki Tamami、Takashima Tsutomu、Tomita Shuhei、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  Journal of Cancer Research and Clinical Oncology
  
  Volume: 144 Issue: 8 Pages: 1547-1559
- DOI
  10.1007/s00432-018-2670-0
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17K13225
[Journal Article] Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes2018
- Author(s)
  Asano Y, Kashiwagi S, Goto W, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 38 Issue: 4 Pages: 2311-2321
- DOI
  10.21873/anticanres.12476
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17H07023
[Journal Article] Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy2018
- Author(s)
  Goto Wataru、Kashiwagi Shinichiro、Asano Yuka、Takada Koji、Takahashi Katsuyuki、Hatano Takaharu、Takashima Tsutomu、Tomita Shuhei、Motomura Hisashi、Ohsawa Masahiko、Hirakawa Kosei、Ohira Masaichi
- Journal Title
  
  ESMO Open
  
  Volume: 3 Issue: 6 Pages: e000305-e000305
- DOI
  10.1136/esmoopen-2017-000305
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559, KAKENHI-PROJECT-17H07023
[Journal Article] Mesenchymal epithelial transition and tumor vascular remodeling in eribulin chemotherapy for breast cancer2018
- Author(s)
  Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Takashima T, Noda S, Onoda N, Tomita S, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  Anticancer Research
  
  Volume: 38 Pages: 401-410
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K10559
[Journal Article] Use of tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer.2017
- Author(s)
  Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Noda S, Takashima T, Onoda N, Tomita S, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  PLoS ONE
  
  Volume: 12 Issue: 2 Pages: e0170634-e0170634
- DOI
  10.1371/journal.pone.0170634
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957, KAKENHI-PROJECT-15K15054, KAKENHI-PROJECT-17K08602, KAKENHI-PROJECT-17K10559
[Journal Article] Expression and clinical significance of androgen receptor in triple-negative breast cancer.2017
- Author(s)
  Asano Y, Kashiwagi S, Goto W, Takada K, Tanaka S, Morisaki T, Takashima T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  Cancers
  
  Volume: 9 Issue: 1 Pages: 4-4
- DOI
  10.3390/cancers9010004
- NAID
  130005161483
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461957, KAKENHI-PROJECT-17K13225, KAKENHI-PROJECT-17H07023
[Journal Article] A case of multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis.2017
- Author(s)
  Sera T, Kashiwagi S, Takashima T, Asano Y, Goto W, Iimori N, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  BMC Res Notes
  
  Volume: 10 Issue: 1 Pages: 55-55
- DOI
  10.1186/s13104-017-2375-5
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer2017
- Author(s)
  Kashiwagi S, Fukushima W, Asano Y, Goto W, Takada K, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.
- Journal Title
  
  BMC Cancer
  
  Volume: 17 Issue: 1 Pages: 604-604
- DOI
  10.1186/s12885-017-3598-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10559
[Journal Article] Platelet lymphocyte ratio as a useful predictor of the therapeutic effect of neoadjuvant chemotherapy in breast cancer.2016
- Author(s)
  Asano Y, Kashiwagi S, Onoda N, Noda S, Kawajiri H, Takashima T, Ohsawa M, Kitagawa S, Hirakawa K.
- Journal Title
  
  PLoS ONE
  
  Volume: 11 Issue: 7 Pages: e0153459-e0153459
- DOI
  10.1371/journal.pone.0153459
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Platelet lymphocyte ratio as a useful predictor of the therapeutic effect of neoadjuvant chemotherapy in breast cancer2016
- Author(s)
  Yuka Asano, Shinichiro Kashiwagi, Naoyoshi Onoda, Satoru Noda, Hidemi Kawajiri, Tsutomu Takashima, Masahiko Ohsawa, Seiichi Kitagawa, Kosei Hirakawa
- Journal Title
  
  PLOS ONE
  
  Volume: 5
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer.2016
- Author(s)
  Asano Y, Kashiwagi S, Onoda N, Noda S, Kawajiri H, Takashima T, Ohsawa M, Kitagawa S, Hirakawa K.
- Journal Title
  
  Ann Surg Oncol
  
  Volume: 23 Issue: 4 Pages: 1104-1110
- DOI
  10.1245/s10434-015-4934-0
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Growth arrest by activated BRAF and MEK inhibition in human anaplastic thyroid cancer cells.2016
- Author(s)
  Kurata K, Onoda N, Noda S, Kashiwagi S, Asano Y, Hirakawa K, Ohira M.
- Journal Title
  
  Int J Oncol.
  
  Volume: 49 Issue: 6 Pages: 2303-2308
- DOI
  10.3892/ijo.2016.3723
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer.2016
- Author(s)
  Asano Y, Kashiwagi S, Onoda N, Kurata K, Morisaki T, Noda S, Takashima T, Ohsawa M, Kitagawa S, Hirakawa K.
- Journal Title
  
  Br J Cancer
  
  Volume: 12 Issue: 1 Pages: 14-20
- DOI
  10.1038/bjc.2015.434
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] 【甲状腺未分化癌　最近の進捗】甲状腺未分化癌に対する集学的治療2016
- Author(s)
  野田諭, 小野田尚佳, 柏木伸一郎, 徳本真央, 田内幸枝, 高島勉, 平川弘聖, 大平雅一
- Journal Title
  
  日本内分泌・甲状腺外科学会雑誌
  
  Volume: 33 Pages: 170-173
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer.2016
- Author(s)
  Asano Y, Kashiwagi S, Goto W, Kurata K, Noda S, Takashima T, Onoda N, Tanaka S, Ohsawa M, Hirakawa K.
- Journal Title
  
  Br J Surg
  
  Volume: 103 Issue: 7 Pages: 845-854
- DOI
  10.1002/bjs.10127
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Nonfunctional adrenocortical carcinoma initially presenting as retroperitoneal haemorrhage.2015
- Author(s)
  Kashiwagi S, Amano R, Onoda N, Noda S, Hirata K, Asano Y, Kurata K, Miura K, Yamazoe S, Kimura K, Ohsawa M, Kitagawa S, Hirakawa K.
- Journal Title
  
  BMC Surgery
  
  Volume: 15 Issue: 1 Pages: 46-46
- DOI
  10.1186/s12893-015-0031-3
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957, KAKENHI-PROJECT-25461992
[Journal Article] T-stage and positive sentinel nodes ratio are the useful factors to predict non-sentinel node metastasis in breast cancer patients with macro-metastasis in the sentinel node.2015
- Author(s)
  Noda S, Onoda N, Asano Y, Kurata K, Kashiwagi S, Kawajiri H, Takashima T, Hirakawa K.
- Journal Title
  
  Int J Surg
  
  Volume: 14 Pages: 56-60
- DOI
  10.1016/j.ijsu.2015.01.006
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Nestin expression as an independent indicator of poor prognosis for patients with anaplastic thyroid cancer.2015
- Author(s)
  Kurata K, Onoda N, Noda S, Kashiwagi S, Asano Y, Kawajiri H, Takashima T, Tanaka S, Ohsawa M, Hirakawa K.
- Journal Title
  
  Oncol Lett
  
  Volume: 2 Pages: 850-856
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] A case of bilateral pheochromocytoma during pregnancy.2015
- Author(s)
  Kitayama K, Kashiwagi S, Amano R, Noda S, Ohira G, Yamazoe S, Kimura K,Hamamoto K, Hamuro A, Ohsawa M, Onoda N, Hirakawa K.
- Journal Title
  
  BMC Surg.
  
  Volume: 15 Issue: 1 Pages: 55-55
- DOI
  10.1186/s12893-015-0041-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] Partial mastectomy using manual blunt dissection (MBD) in early breast cancer.2015
- Author(s)
  Kashiwagi S, Onoda N, Asano Y, Kurata K, Morisaki T, Noda S, Kawajiri H, Takashima T, Hirakawa K.
- Journal Title
  
  BMC Surg.
  
  Volume: 15 Issue: 1 Pages: 117-117
- DOI
  10.1186/s12893-015-0102-5
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study.2015
- Author(s)
  Kashiwagi S, Onoda N, Asano Y, Kurata K, Noda S, Kawajiri H, Takashima T, Ohsawa M, Kitagawa S, Hirakawa K.
- Journal Title
  
  World J Surg Oncol
  
  Volume: 13 Issue: 1 Pages: 53-53
- DOI
  10.1186/s12957-015-0471-3
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Significant cytostatic effect of everolimus on a gefitinib-resistant anaplastic thyroid cancer cell line harboring PI3KCA gene mutation.2015
- Author(s)
  Onoda N, Nakamura M, Aomatsu N, Noda S, Kashiwagi S, Kurata K, Uchino S, Hirakawa K.
- Journal Title
  
  Mol Clin Oncol
  
  Volume: 3 Pages: 522-526
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] The significance and the predictive factors of microscopic lymph node metastasis in patients with clinically node negative papillary thyroid cancer: A retrospective cohort study.2015
- Author(s)
  Noda S, Onoda N, Morisaki T, Kashiwagi S, Takashima T, Hirakawa K.
- Journal Title
  
  Int J Surg
  
  Volume: 20 Pages: 52-57
- DOI
  10.1016/j.ijsu.2015.06.023
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer.2015
- Author(s)
  Kawajiri H, Takashima T, Kashiwagi S, Noda S, Onoda N, Hirakawa K.
- Journal Title
  
  Expert Rev Anticancer Ther.
  
  Volume: 15 Issue: 1 Pages: 17-26
- DOI
  10.1586/14737140.2015.992418
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma.2014
- Author(s)
  Nakamura M, Onoda N, Noda S, Kashiwagi S, Aomatsu N, Kurata K, Kawajiri H, Takashima T, Ishikawa T, Hirakawa K..
- Journal Title
  
  Mol Clin Oncol
  
  Volume: 2 Pages: 226-232
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] 20.E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid mirocarcinoma.2014
- Author(s)
  Nakamura M, Onoda N, Noda S, Kashiwagi S, Aomatsu N, Kurata K, Kawajiri H, Takashima T, Ishikawa T, Hirakawa K.
- Journal Title
  
  Mol Clin Oncol
  
  Volume: 2 Pages: 226-232
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] A rare recurrence of bilateral breast cancer in the esophagus coincidentally associated with primary gastric cancer: a case report.2014
- Author(s)
  Kashiwagi S, Onoda N, Asano Y, Noda S, Kawajiri H, Takashima T, Ishikawa T, Hirakawa K.
- Journal Title
  
  J Med Case Rep
  
  Volume: 8 Issue: 1 Pages: 58-58
- DOI
  10.1186/1752-1947-8-58
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Establishment, characterization and comparison of seven authentic anaplastic thyroid cancer cell lines retaining clinical features of the original tumors.2014
- Author(s)
  Onoda N, Nakamura M, Aomatsu N, Noda S, Kashiwagi S, Hirakawa K.
- Journal Title
  
  World J Surg
  
  Volume: 38 Issue: 3 Pages: 688-695
- DOI
  10.1007/s00268-013-2409-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25461992, KAKENHI-PROJECT-26461957
[Journal Article] Reactive lymphoid hyperplasia of the thyroid followed by systemic autoimmune diseases: a case report.2014
- Author(s)
  Onoda N, Ohsawa M, Kawajiri H, Noda S, Kashiwagi S, Takashima T, Hirakawa K.
- Journal Title
  
  J Med Case Rep.
  
  Volume: 8 Issue: 1 Pages: 247-247
- DOI
  10.1186/1752-1947-8-247
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] 21.Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer.2014
- Author(s)
  Kawajiri H, Takashima T, Aomatsu N, Kashiwagi S, Noda S, Onoda N, Ishikawa T, Hirakawa K.
- Journal Title
  
  Oncology Letters
  
  Volume: 7 Pages: 663-668
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] 24.Strategy of operative treatment of hyperparathyroidism using US scan and 99mTc-MIBI SPECT/CT.2014
- Author(s)
  Noda S, Onoda N, Kashiwagi S, Kawajiri H, Takashima T, Ishikawa T, Yoshida A, Higashiyama S, Kawabe J, Imanishi Y, Tahara H, Inaba M, Osawa M, Hirakawa K.
- Journal Title
  
  Endcrine J
  
  Volume: 61 Pages: 225-230
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] 19.Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline.2014
- Author(s)
  Aomatsu N, Yashiro M, Kashiwagi S, Kawajiri H, Takashima T, Ohsawa M, Wakasa K, Hirakawa K.
- Journal Title
  
  BMC Cancer
  
  Volume: 14 Issue: 1 Pages: 400-400
- DOI
  10.1186/1471-2407-14-400
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461957
[Journal Article] Strategy of operative treatment of hyperparathyroidism using US scan and (99m)Tc-MIBI SPECT/CT.2013
- Author(s)
  Noda S, Onoda N, Kashiwagi S, Kawajiri H, Takashima T, Ishikawa T, Yoshida A, Higashiyama S, Kawabe J, Imanishi Y, Tahara H, Inaba M, Osawa M, Hirakawa K.
- Journal Title
  
  Endocr J
  
  Volume: 61 Pages: 225-230
- NAID
  130004443938
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] 甲状腺未分化癌の臨床像　緩和医療介入の実際2013
- Author(s)
  中尾吉孝, 松田泰範, 下村祥子, 鶴田理恵, 柏木伸一郎, 野田諭, 小野田尚佳, 平川弘聖
- Journal Title
  
  日本内分泌・甲状腺外科学会雑誌
  
  Volume: 30 Pages: 182-186
- NAID
  130004977223
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] High efficacy of chemoradiation therapy sensitized by weekly docetaxel for anaplastic thyroid cancer.2013
- Author(s)
  Onoda N, Kashiwagi S, Noda S, Kawajiri H, Takashima T, Ishikawa T, Hirakawa K.
- Journal Title
  
  Anticancer Res
  
  Volume: 33 Pages: 3445-3448
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] 甲状腺未分化癌の臨床像　手術療法の意義2013
- Author(s)
  小野田尚佳, 野田諭, 柏木伸一郎, 倉田研人, 川尻成美, 高島勉, 石川哲郎, 平川弘聖
- Journal Title
  
  日本内分泌・甲状腺外科学会雑誌
  
  Volume: 30 Pages: 175-178
- NAID
  130004977221
- Data Source
  KAKENHI-PROJECT-25461992
[Journal Article] 甲状腺未分化癌の治療経験からみた臨床試験の重要性2013
- Author(s)
  小野田尚佳、川尻成美, 野田諭, 柏木伸一郎, 中村雅憲, 高島勉, 平川弘聖
- Journal Title
  
  日本内分泌・甲状腺外科学会雑誌
  
  Volume: 30 Pages: 212-215
- NAID
  130004977230
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 乳癌術前化学療法における免疫微小環境のダイナミックモニタリング2019
- Author(s)
  柏木伸一郎, 浅野有香, 高田晃次, 後藤　航, 森崎珠実, 野田　諭, 高島　勉, 小野田尚佳, 平川弘聖, 大平雅一
- Organizer
  第119回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K10559
[Presentation] メタボロミクスを用いたエリブリン特異的薬剤特性の検証2018
- Author(s)
  柏木伸一郎, 浅野有香, 後藤　航, 高田晃次, 森崎珠実, 野田　諭, 高島　勉, 小野田尚佳, 平川弘聖, 大平雅一
- Organizer
  第26回日本乳癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K10559
[Presentation] Predicting therapeutic effect by on tumor-infiltrating lymphocytes (TILs) in endocrine therapy for stage IV breast cancer2016
- Author(s)
  Shinichiro Kashiwagi, Yuka Asano, Wataru Goto, Koji Takada, Tsutomu Takashima, Tamami Morisaki, Satoru Noda, Naoyoshi Onoda, Masahiko Ohsawa, Kosei Hirakawa, Masaichi Ohira
- Organizer
  San Antonio Breast Cancer Symposium (SABCS)
- Place of Presentation
  San Antonio, Texas, USA
- Year and Date
  2016-12-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461957
[Presentation] 甲状腺癌のリスクアダプテッドマネージメントにおけるリスク分類乳頭癌のリンパ節転移と郭清範囲2016
- Author(s)
  野田諭, 小野田尚佳, 浅野有香, 田内幸枝, 徳本真央, 森崎珠実, 柏木伸一郎, 高島勉, 平川弘聖, 大平雅一
- Organizer
  第49回　日本甲状腺外科学会学術集会
- Place of Presentation
  甲府富士屋ホテル(山梨県甲府市）
- Year and Date
  2016-10-26
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] Prediction of The Treatment Response to Docetaxel, Trastuzumab and Pertuzumab Combination Regimen Chemotherapy in Breast Cancer using TILs2016
- Author(s)
  Shinichiro Kashiwagi, Tsutomu Takashima, Yuka Asano, Wataru Goto, Koji Takada, Tamami Morisaki, Satoru Noda, Naoyoshi Onoda, Kosei Hirakawa, Masaichi Ohira
- Organizer
  4th Federation of Asian Clinical Oncology (FACO)
- Place of Presentation
  Amoi, China
- Year and Date
  2016-09-22
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461957
[Presentation] 食道憩室を合併した甲状腺癌の1例2016
- Author(s)
  飯盛望, 小野田尚佳, 瀬良知央, 田内幸枝, 徳本真央, 柏木伸一郎, 野田諭, 高島勉, 大澤政彦, 平川弘聖, 大平雅一
- Organizer
  第49回　日本甲状腺外科学会学術集会
- Place of Presentation
  甲府富士屋ホテル(山梨県甲府市）
- Year and Date
  2016-10-26
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] シンポジウム　進行性甲状腺分泌癌の化学療法-臨床および基礎　甲状腺未分化癌に対する化学療法の認容性、安全性に関する前向き研究2016
- Author(s)
  小野田尚佳、野田諭、徳本真央、柏木伸一郎、平川弘聖
- Organizer
  第89回　日本内分泌学会
- Place of Presentation
  京都国際会議場（京都府京都市）
- Year and Date
  2016-04-22
- Invited
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] ワークショップ　甲状腺未分化癌、低分化癌Update　甲状腺未分化癌 Update2016
- Author(s)
  小野田尚佳、野田諭、徳本真央、柏木伸一郎、平川弘聖
- Organizer
  第28回　日本内分泌外科学会総会
- Place of Presentation
  ロイヤルホール横浜（神奈川県横浜市）
- Year and Date
  2016-05-21
- Invited
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] Prediction of the treatment response to eribulin chemotherapy in breast cancer using tumor-infiltrating lymphocytes (TILs)2016
- Author(s)
  Shinichiro Kashiwagi, Yuka Asano, Wataru Goto, Kento Kurata, Tamami Morisaki, Satoru Noda, Tsutomu Takashima, Naoyoshi Onoda, Sayaka Tanaka, Masahiko Ohsawa, Masaichi Ohira, Kosei Hirakawa
- Organizer
  American Association for Cancer Research (AACR)
- Place of Presentation
  New Orleans, Louisiana, USA
- Year and Date
  2016-04-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461957
[Presentation] 再発甲状腺癌の治療 Sorafenibを1年間以上投与したRI抵抗性・再発甲状腺分化癌の4例2016
- Author(s)
  小野田尚佳, 野田諭, 徳元真央, 田内幸枝, 飯盛望, 瀬良知央, 柏木伸一郎, 高島勉, 平川弘聖, 大平雅一
- Organizer
  第49回　日本甲状腺外科学会学術集会
- Place of Presentation
  甲府富士屋ホテル(山梨県甲府市）
- Year and Date
  2016-10-26
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 血友病を合併したBasedow病の1手術例2016
- Author(s)
  瀬良知央, 小野田尚佳, 飯盛望, 後藤航, 田内幸枝, 徳本真央, 柏木伸一郎, 野田諭, 高島勉, 武岡康信, 中根孝彦, 平川弘聖, 大平雅一
- Organizer
  第49回　日本甲状腺外科学会学術集会
- Place of Presentation
  甲府富士屋ホテル(山梨県甲府市）
- Year and Date
  2016-10-26
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 前胸部に皮膚瘻を形成した甲状腺乳頭癌の1切除例2016
- Author(s)
  野田諭, 小野田尚佳, 浅野有香, 田内幸枝, 徳本真央, 柏木伸一郎, 高島勉, 平川弘聖, 大平雅一
- Organizer
  第49回　日本甲状腺外科学会学術集会
- Place of Presentation
  甲府富士屋ホテル(山梨県甲府市）
- Year and Date
  2016-10-26
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺全摘後の治療成績から見た進行甲状腺乳頭癌に対する治療戦略2016
- Author(s)
  小野田尚佳, 野田諭, 柏木伸一郎, 倉田研人, 浅野有香, 石川哲郎, 徳本真央, 森崎珠実, 川尻成美, 高島勉, 平川弘聖
- Organizer
  第116回　日本外科学会総会
- Place of Presentation
  大阪国際会議場（大阪府大阪市）
- Year and Date
  2016-04-14
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌治療の最前線2015
- Author(s)
  小野田尚佳、野田諭、倉田研人、中村雅憲、延原泰行、浅野有香、柏木伸一郎、平川弘聖
- Organizer
  日本外科系連合学会
- Place of Presentation
  京王プラザホテル（東京都新宿区）
- Year and Date
  2015-06-19
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌に対する新規B-Raf阻害剤、MEK阻害剤の抗腫瘍効果の検討2015
- Author(s)
  倉田研人, 小野田尚佳, 野田諭, 柏木伸一郎, 浅野有香, 川尻成美, 高島勉, 平川弘聖
- Organizer
  日本甲状腺外科学会
- Place of Presentation
  青山ダイヤモンドホール（東京都港区）
- Year and Date
  2015-10-29
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] CYTOSTATIC EFFECT OF EVEROLIMUS ON A GEFITINIB-RESISTANT ANAPLASTIC THYROID CANCER CELL LINE WITH PI3KCA MUTATION2015
- Author(s)
  N Onoda, M Nakamura, K Kurata, S Noda, S Kashiwagi, Y Asano, T Takashima, K Hirakawa
- Organizer
  Ｉｎｔｅｒｎａｔｉｏｎａｌ　Ｓｕｒｇｉｃａｌ　Ｗｅｅｋ/　Ｉｎｔｅｒｎａｔｉｏｎａｌ　Ａｓｓｏｃｉａｔｉｏｎ　ｏｆ　Ｅｎｄｏｃｒｉｎｅ　Ｓｕｒｇｅｏｎｓ
- Place of Presentation
  バンコク、タイ王国
- Year and Date
  2015-08-23
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌細胞株を用いた分子標的治療の基礎的検討2015
- Author(s)
  小野田尚佳、中村雅憲、倉田研人、野田　諭、柏木伸一郎、浅野有香、高島　勉、内野眞也、平川弘聖
- Organizer
  第27回日本内分泌外科学会総会
- Place of Presentation
  コラッセ福島（福島県福島市）
- Year and Date
  2015-05-29
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌に対する新規 MEK 阻害剤 Trametinib の抗腫瘍効果2015
- Author(s)
  倉田研人、小野田尚佳、野田　論、柏木伸一郎、浅野有香、川尻成美、高島　勉、平川弘聖
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場（愛知県名古屋市）
- Year and Date
  2015-10-10
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌に対する B-raf 阻害剤の抗腫瘍効果2015
- Author(s)
  倉田研人、小野田尚佳、野田　諭、柏木伸一郎、浅野有香、川尻成美、高島　勉、平川弘聖
- Organizer
  第53回日本癌治療学会学術集会
- Place of Presentation
  京都国際会議場（京都府京都市）
- Year and Date
  2015-10-31
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 集学的治療抵抗性の再発甲状腺未分化癌に対してLenvatinibを投与した1例2015
- Author(s)
  小野田尚佳、徳本真央、松田博人、野田諭、柏木伸一郎、倉田研人、浅野有香、高島勉、平川弘聖
- Organizer
  日本甲状腺外科学会
- Place of Presentation
  青山ダイヤモンドホール（東京都港区）
- Year and Date
  2015-10-29
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌治療の最前線2015
- Author(s)
  小野田尚佳、野田諭、倉田研人、中村雅憲、延原泰行、浅野有香、柏木伸一郎、平川弘聖
- Organizer
  第40回日本外科系連合学会学術集会
- Place of Presentation
  京王プラザホテル（東京都・新宿区）
- Year and Date
  2015-06-19
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌に対する治療戦略2013
- Author(s)
  小野田尚佳、野田諭、柏木伸一郎、川尻成美、高島勉、平川弘聖
- Organizer
  第75回日本臨床外科学会総会
- Place of Presentation
  名古屋国際会議場、名古屋市
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺腫瘍経過観察中に未分化転化を起こし切除しえた1 例2013
- Author(s)
  倉田研人、小野田尚佳、野田諭、柏木伸一郎、川尻成美、高島勉、平川弘聖
- Organizer
  第46回日本甲状腺外科学会学術総会
- Place of Presentation
  愛知県産業労働センター、名古屋
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌に対する個別化した治療戦略2013
- Author(s)
  小野田尚佳、中村雅憲、柏木伸一郎、野田諭、川尻成美、高島勉、平川弘聖
- Organizer
  第113回日本外科学会定期学術集会
- Place of Presentation
  福岡国際会議場、福岡市
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌細胞株を用いた分子標的治療の基礎的検討
- Author(s)
  小野田尚佳、中村雅憲、倉田研人、野田諭、柏木伸一郎、浅野有香、高島勉、＊内野眞也、平川弘聖
- Organizer
  第27回日本内分泌外科学会総会
- Place of Presentation
  コラッセ福島（福島県・福島市）
- Year and Date
  2015-05-28 – 2015-05-29
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] Nestin is an independent molecular prognostic factor in patients with anaplastic thyroid carcinoma.
- Author(s)
  Kurata K, Onoda N, Noda S, Kashiwagi S, Asano Y, Kawajiri H, Takashima T, Tanaka S, Ohsawa M, Hirakawa K
- Organizer
  American Association for Cancer Research　Annual Meeting 2014
- Place of Presentation
  SanDiego Convention Center (SanDiego, CA）
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] Predictive Value of Neutrophil-Lymphocyte Ratio for the Efficacy of Preoperative Chemotherapy in Triple-negative Breast Cancer
- Author(s)
  Asano Y, Kashiwagi S, Morisaki T, Noda S, Kawajiri H, Takashima T, Onoda N, Hirakawa K.
- Organizer
  American Association for Cancer Research 2015
- Place of Presentation
  Philadelphia (USA)
- Year and Date
  2015-04-18 – 2015-04-22
- Data Source
  KAKENHI-PROJECT-26461957
[Presentation] 甲状腺全摘後の治療成績から見た進行甲状腺乳頭癌に対する治療戦略
- Author(s)
  小野田尚佳、野田諭、柏木伸一郎、倉田研人、浅野有香、森崎珠実、川尻成美、高島勉、石川哲郎、平川弘聖
- Organizer
  第115回日本外科学会定期学術集会
- Place of Presentation
  名古屋国際会議場（愛知県・名古屋市）
- Year and Date
  2015-04-16 – 2015-04-18
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] CYTOSTATIC EFFECT OF EVEROLIMUS ON A GEFITINIB-RESISTANT ANAPLASTIC THYROID CANCER CELL LINE WITH PI3KCA MUTATION
- Author(s)
  N Onoda, M Nakamura, K Kurata, S Noda, S Kashiwagi, Y Asano, T Takashima, K Hirakawa
- Organizer
  International Association of Endocrine Surgeons in WCS 2015
- Place of Presentation
  Centara Grand & Bangkok Convention Centre at Central World（Bangkok, Thailand）
- Year and Date
  2015-08-23 – 2015-08-27
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 16.Expression and clinical significance of androgen receptor in triple-negative breast cancer.
- Author(s)
  Asano Y, Kashiwagi S, Kurata K, Morisaki T, Noda S, Kawajiri H, Takashima T, Onoda N, Maeda K, Hirakawa K.
- Organizer
  39th European Society for Medical Oncology
- Place of Presentation
  Madrid (Spain)
- Year and Date
  2014-09-26 – 2014-09-30
- Data Source
  KAKENHI-PROJECT-26461957
[Presentation] Establishment, characterization and comparison of seven authentic anaplastic thyroid cancer cell lines retaining clinical features of the original tumors.
- Author(s)
  Onoda N, Nakamura M, Aomatsu N, Noda S, Kashiwagi S, Hirakawa K.
- Organizer
  International Association of Endocrine Surgeons
- Place of Presentation
  Helsinki Exhibition and Convention Centre, Helsinki, Finland
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 甲状腺未分化癌での間葉系マーカーの発現と臨床的意義
- Author(s)
  小野田尚佳、倉田研人、野田諭、柏木伸一郎、浅野有香、森崎珠実、川尻成美、高島勉、平川弘聖
- Organizer
  第76回日本臨床外科学会
- Place of Presentation
  ホテルハマツ（福島県・郡山市）
- Year and Date
  2014-11-20 – 2014-11-22
- Data Source
  KAKENHI-PROJECT-25461992
[Presentation] 15.TLE3 is a useful marker for predicting the therapeutic effect of eribulin chemotherapy for triple-negative breast cance.
- Author(s)
  Kashiwagi S, Asano Y, Kurata K, Morisaki T, Noda S, Kawajiri H, Takashima T, Onoda N, Maeda K, Hirakawa K.
- Organizer
  39th European Society for Medical Oncology
- Place of Presentation
  Madrid (Spain)
- Year and Date
  2014-09-26 – 2014-09-30
- Data Source
  KAKENHI-PROJECT-26461957

1. 藤田寿一 (30212187)

# of Collaborated Projects: 4 results

# of Collaborated Products: 5 results
2. 高島勉 (80336776)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
3. Onoda Naoyoshi (30295703)

# of Collaborated Projects: 1 results

# of Collaborated Products: 39 results
4. 野田諭 (20382103)

# of Collaborated Projects: 1 results

# of Collaborated Products: 39 results
5. 川尻成美 (40597283)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 大平雅一 (90203926)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 浅野有香 (10806376)

# of Collaborated Projects: 1 results

# of Collaborated Products: 11 results
8. 加藤隆幸 (50343413)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 富田修平

# of Collaborated Projects: 0 results

# of Collaborated Products: 12 results
10. 高田晃次

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

KASHIWAGI SHINITIROU 柏木 伸一郎

Kashiwagi Shinichiro 柏木 伸一郎

Research Projects

Research Products

Co-Researchers

Development of Breast Cancer Treatment Strategies Based on Dynamic Changes in Tumor Microenvironment Induced by Drug ModificationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Verification of systemic response and tumor microenvironment change in triple-negative breast cancer based on immune responsePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The establishment of an innovative method for isolation of tumor endothelial cells (TECs) supporting the growth of tumor and the application to cancer therapy

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Clinical validation of microenvironmental control related to malignant trait acquisition of triple negative breast cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clinical significance and molecular mechanism elucidation of E-cadherin expression in triple-negative breast cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Involvement of EMT in anaplastic thyroid carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Clinical verification on the relationship between serum lipid metabolism and the immune activity in breast cancer patients treated with neoadjuvant chemotherapy.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Factor analysis of intraoperative bleeding loss and its impact on prognosis in breast cancer.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical verification of the predictors for febrile neutropenia in breast cancer patients treated with neoadjuvant chemotherapy.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Eribulin treatment promotes re-expression of estrogen receptor in endocrine therapy-resistant hormone receptor-positive breast cancer cells.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Outcome prediction after neoadjuvant chemotherapy (NAC) for breast cancer, using tumor-infiltrating lymphocytes within fibrotic foci of tumor stroma (FF-TILs).2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical significance of expression of immunoadjuvant molecules (LAG-3, TIM-3, OX-40) in neoadjuvant chemotherapy for breast cancer.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment2020

Author(s)

Journal Title

DOI

KASHIWAGI SHINITIROU 柏木伸一郎

Kashiwagi Shinichiro 柏木伸一郎